FDA label
What is Tyrvaya used for?
Tyrvaya contains varenicline. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “TYRVAYA (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Tyrvaya?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Tyrvaya, spray
Indications and Usage, quoted from the label by Oyster Point Pharma, Inc. (NDA213978). Cross-references to other label sections are left out.
TYRVAYA (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.
Source: DailyMed label, set id 014c93dc-5737-479c-a9f0-aaadac1ac298, version 16, effective July 15, 2026. NDC 73521-030, one of 1 listing for this product.
Questions
What is Tyrvaya used for?
The FDA label says: “TYRVAYA (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.”
What drug class is Tyrvaya?
FDA lists varenicline in the Partial Cholinergic Nicotinic Agonist and Cholinergic Receptor Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Tyrvaya
- Is Tyrvaya a controlled substance?Federal schedule
- Generic for TyrvayaFDA Orange Book
- What is Varenicline used for?FDA label uses
- Is Varenicline a controlled substance?Federal schedule
- Generic for ChantixFDA Orange Book
- Partial Cholinergic Nicotinic Agonists listFDA drug class
- Cholinergic Receptor Agonists listFDA drug class
- NDC 73521-030Tyrvaya NDC record